In some cases, doctors may start with a lower dose than usual or adjust the increase schedule more slowly to monitor how it affects psoriasis symptoms
The narrative review on supplements during GLP-1 therapy A narrative review published in a peer-reviewed journal specifically examined dietary supplement considerations during GLP-1 receptor agonist treatment
Svanstrm H, Ueda P, Melbye M, Eliasson B, Svensson AM, Franzn S, Gudbjrnsdottir S, Hveem K, Jonasson C, Pasternak B: Use of liraglutide and risk of major cardiovascular events: a register-based cohort study in Denmark and Sweden
(5.7) Adverse Reactions/Side Effects Adverse reactions reported in 5% of patients treated with JANUVIA and more commonly than in patients treated with placebo are: upper respiratory tract infection, nasopharyngitis and headache